Lv31
330 积分 2024-11-01 加入
PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation
31分钟前
待确认
MicroRNA-224 orchestrates BMP and TGFβ signaling and is a therapeutic target in preclinical pulmonary arterial hypertension
43分钟前
已完结
The Right Ventricle in Pulmonary Arterial Hypertension: Comprehensive Pathomechanism and Crosstalk
6天前
已关闭
Cardiomyocyte nucleoporin 35 regulates pathological cardiac remodelling through Wif1
8天前
已完结
HNRNPA2B1: RNA-Binding Protein That Orchestrates Smooth Muscle Cell Phenotype in Pulmonary Arterial Hypertension
8天前
已完结
Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice
9天前
已完结
Towards a Better Understanding of Heart‐Lung Interactions in Pulmonary Vascular Disease
9天前
已完结
Therapeutic potential of magnesium diboride nanosheets in PAH-associated right heart failure: Integrated multi-omics analysis reveals ferroptosis suppression via LC3/ATG5/NCOA4/FTH1 pathway
9天前
已完结
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
9天前
已完结
Risk stratification and treatment goals in pulmonary arterial hypertension
1个月前
已完结
皖公网安备34019202002308
